1. The WHO Regional Director for Europe launched the Knowledge Hub on Health and Migration, a multi-stakeholder platform for sharing knowledge and improving public policies around health needs of migrants.
2. An analysis of health indicators in Sicily found higher infant mortality, lower life expectancy, and social inequalities compared to other EU regions in Italy.
3. Reducing health inequities will require action on social, economic, and environmental determinants of health across the life course from early childhood through working years.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the School of Public Health Management (Chisinau, Republic of Moldova, 24 November 2016)
Contemporary health policy context in Europe: some opportunities and challenges
Presentation by Dr Zsuzsanna Jakab, WHO Regional Director for Europe. 8 March 2017, Israel
This third edition of Health at a Glance: Europe presents key indicators of health and health systems in the 28 European Union member states, four candidate countries and three EFTA countries. The selection of indicators is based largely on the European Core Health Indicators (ECHI), a set of indicators that has been developed to guide the reporting of health statistics in the European Union. This is complemented by additional indicators on quality of care, access to care and health expenditure, building on the OECD expertise in these areas.
Compared with the previous edition, this third edition includes a greater number of ECHI indicators. It also includes a new chapter on access to care, including indicators related to financial access, geographic access and timely access.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 67th session of the WHO Regional Committee for Europe (Budapest, Hungary, 11–14 September 2017)
Dr Zsuzsanna Jakab, WHO Regional Director for Europe,Policy Dialogue on Health System and Public Health Reform in Cyprus: Health in the 21st Century, 26–27 September 2017, Nicosia, Cyprus
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the School of Public Health Management (Chisinau, Republic of Moldova, 24 November 2016)
Contemporary health policy context in Europe: some opportunities and challenges
Presentation by Dr Zsuzsanna Jakab, WHO Regional Director for Europe. 8 March 2017, Israel
This third edition of Health at a Glance: Europe presents key indicators of health and health systems in the 28 European Union member states, four candidate countries and three EFTA countries. The selection of indicators is based largely on the European Core Health Indicators (ECHI), a set of indicators that has been developed to guide the reporting of health statistics in the European Union. This is complemented by additional indicators on quality of care, access to care and health expenditure, building on the OECD expertise in these areas.
Compared with the previous edition, this third edition includes a greater number of ECHI indicators. It also includes a new chapter on access to care, including indicators related to financial access, geographic access and timely access.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 67th session of the WHO Regional Committee for Europe (Budapest, Hungary, 11–14 September 2017)
Dr Zsuzsanna Jakab, WHO Regional Director for Europe,Policy Dialogue on Health System and Public Health Reform in Cyprus: Health in the 21st Century, 26–27 September 2017, Nicosia, Cyprus
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 21st Congress of the European Association of Dental Public Health (1 October 2016 Budapest)
Although HIV is preventable through effective public health measures, significant HIV transmission continues in Europe. In 2015, almost 30 000 people were diagnosed in European Union and European Economic Area Member States; a rate of 6.3 cases in every 100 000 people (when adjusted for reporting delay).
This report, prepared jointly with the WHO Regional Office for Europe, presents data on HIV and AIDS for the whole European Region, including the EU and EEA countries. Analyses are provided for the EU and EEA region.
In 2014, over 57 000 new cases of hepatitis B and C were reported. 22 442 cases of hepatitis B virus infection were reported in 30 EU/EEA Member States and 35 321 cases of hepatitis C were reported from 28 EU/EEA Member States.
Presented at the 66th session of the WHO Regional Committee for Europe by:
Dr Oleg Chestnov, Assistant Director-General, WHO
Dr Jill Farrington, Acting Head, NCD Project Office, Moscow
Dr Gauden Galea, Director, Noncommunicable Diseases and
Promoting Health through the Life-course, WHO/Europe
An overview on how European countries have been responding to the HIV epidemic since 2004 based on the commitments as outlined in the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia.
Surveillance data from 2013 show high numbers of newly diagnosed hepatitis B and C cases notified across Europe. Chronic cases dominate across both diseases with a marked variation between countries: in 2013, 19 930 cases of hepatitis B virus infection were reported in 28 EU/EEA Member States, a crude rate of 4.4 per 100 000 population. 26 EU/ EEA Member States recorded 32 512 cases of hepatitis C resulting in a crude rate of 9.9 per 100 000 population.
Is Europe ready for elimination of hepatitis B and C? The World Health Organization (WHO) will launch a global strategy on viral hepatitis in 2016 with the aim to eliminate hepatitis B and C as public health threats by 2030. The joint poster from ECDC, EMCDDA and WHO/Euro looks at the current availability of data for each of the core indicators and how existing gaps in data availability could be addressed.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Julia del Amo, Instituto de Salud Carlos III, Madrid
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the Advanced Training and Conference on Health Economics (24 June 2015, Budapest, Hungary)
Teymur Noori, ECDC
22nd International AIDS Conference, Amsterdam 2018
2018 European African HIV/AIDS & Hepatitis C Community Summit. "Our Voices Matter for a lasting solution!!"
ALE Presentation: A Multiple Cause Analysis of Massachusetts Trends in HIV an...David Meyers
In this presentation that I created for my Applied Learning Experience for my Master's education, I outline trends over the past ten years in HIV and Hepatitis C Mortality from across the state of Massachusetts.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 21st Congress of the European Association of Dental Public Health (1 October 2016 Budapest)
Although HIV is preventable through effective public health measures, significant HIV transmission continues in Europe. In 2015, almost 30 000 people were diagnosed in European Union and European Economic Area Member States; a rate of 6.3 cases in every 100 000 people (when adjusted for reporting delay).
This report, prepared jointly with the WHO Regional Office for Europe, presents data on HIV and AIDS for the whole European Region, including the EU and EEA countries. Analyses are provided for the EU and EEA region.
In 2014, over 57 000 new cases of hepatitis B and C were reported. 22 442 cases of hepatitis B virus infection were reported in 30 EU/EEA Member States and 35 321 cases of hepatitis C were reported from 28 EU/EEA Member States.
Presented at the 66th session of the WHO Regional Committee for Europe by:
Dr Oleg Chestnov, Assistant Director-General, WHO
Dr Jill Farrington, Acting Head, NCD Project Office, Moscow
Dr Gauden Galea, Director, Noncommunicable Diseases and
Promoting Health through the Life-course, WHO/Europe
An overview on how European countries have been responding to the HIV epidemic since 2004 based on the commitments as outlined in the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia.
Surveillance data from 2013 show high numbers of newly diagnosed hepatitis B and C cases notified across Europe. Chronic cases dominate across both diseases with a marked variation between countries: in 2013, 19 930 cases of hepatitis B virus infection were reported in 28 EU/EEA Member States, a crude rate of 4.4 per 100 000 population. 26 EU/ EEA Member States recorded 32 512 cases of hepatitis C resulting in a crude rate of 9.9 per 100 000 population.
Is Europe ready for elimination of hepatitis B and C? The World Health Organization (WHO) will launch a global strategy on viral hepatitis in 2016 with the aim to eliminate hepatitis B and C as public health threats by 2030. The joint poster from ECDC, EMCDDA and WHO/Euro looks at the current availability of data for each of the core indicators and how existing gaps in data availability could be addressed.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Julia del Amo, Instituto de Salud Carlos III, Madrid
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the Advanced Training and Conference on Health Economics (24 June 2015, Budapest, Hungary)
Teymur Noori, ECDC
22nd International AIDS Conference, Amsterdam 2018
2018 European African HIV/AIDS & Hepatitis C Community Summit. "Our Voices Matter for a lasting solution!!"
ALE Presentation: A Multiple Cause Analysis of Massachusetts Trends in HIV an...David Meyers
In this presentation that I created for my Applied Learning Experience for my Master's education, I outline trends over the past ten years in HIV and Hepatitis C Mortality from across the state of Massachusetts.
Dr Caroline Brown, Programme Manager, Influenza and Other Respiratory Pathogens, Thomas Hofmann, IHR Area Coordinator, Communicable Diseases and Health Security
Д-р Florence FUCHS, Штаб-квартира ВОЗ - Шестьдесят пятая сессия Европейского регионального комитета ВОЗ (Вильнюс, Литва, 14–17 сентября 2015 г.) / Presentation delivered by Dr Florence Fuchs, WHO Headquarters, at the 65th session of the WHO Regional Committee for Europe (Vilnius, Lithuania, 14–17 September 2015)
Dr Gauden Galea, Director, Noncommunicable Diseases and Promoting Health through the Life-course, WHO Regional Office for Europe - Dr Jo Inchley, HBSC International Coordinator, University of St Andrews
Presentation delivered by Claudia Stein, Director - Division of Information, Evidence, Research and Innovation at the 65th session of the WHO Regional Committee for Europe (Vilnius, Lithuania, 14–17 September 2015)
Presentation delivered by Tim Nguyen, Unit leader - Tanja Kuchenmüller, Technical Officer at the 65th session of the WHO Regional Committee for Europe (Vilnius, Lithuania, 14–17 September 2015)
Presentations delivered by Dr Nedret Emiroglu (Director, Division of Communicable Diseases and Health Security at the WHO Regional Office for Europe) - High-level meeting on refugee and migrant health (23-24 November 2015, Rome, Italy)
Presentation delivered by Claudia Stein, Director, Division of Information, Evidence, Research and Innovation, on 15 September 2015, at the 65th session of the WHO Regional Committee for Europe (Vilnius, Lithuania, 14–17 September 2015)
Dr Oleg Chestnov, помощник генерального директора
Dr Jill Farrington, и.о. руководителя офиса проекта по НИЗ в Москве
Dr Gauden Galea, директор
Отдел неинфекционных заболеваний и укрепления здоровья на всех этапах жизни
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 65th session of the WHO Regional Committee for Europe (Vilnius, Lithuania, 14–17 September 2015)
This fourth edition of Health at a Glance: Europe presents key indicators of health and health systems in the 28 EU countries, 5 candidate countries to the EU and 3 EFTA countries. This 2016 edition contains two main new features: two thematic chapters analyse the links between population health and labour market outcomes, and the important challenge of strengthening primary care systems in European countries; and a new chapter on the resilience, efficiency and sustainability of health systems in Europe, in order to align the content of this publication more closely with the 2014 European Commission Communication on effective, accessible and resilient health systems. This publication is the result of a renewed collaboration between the OECD and the European Commission under the broader "State of Health in the EU" initiative, designed to support EU member states in their evidence-based policy making.
Presentation made by Zsuzsanna Jakab, WHO Regional Director for Europe, at the meeting "Health in Action reforming the Greek National Health System to Improve Citizens’ Health", on 5 March 2014, Athens, Greece.
Presentation - Advancing health literacy and social mobilization for the United Nations 2030 Sustainable Development Goals
18 May 2017, Geneva, Switzerland
By Dr Zsuzsanna Jakab, WHO Regional Director for Europe
This presentation is part of the report presented by the WHO Regional Director Zsuzsanna Jakab at the 63rd session of the WHO Regional Committee for Europe in Çeşme Izmir, Turkey, on 16 September 2013.
Presentation delivered by Zsuzsanna Jakab, WHO Regional Director for Europe, at the Meeting of the European Environment and Health Ministerial Board (24 February 2015, Madrid, Spain)
This seventh edition of Health at a Glance provides the latest comparable data on different aspects of the performance of health systems in OECD countries. It provides striking evidence of large variations across countries in the costs, activities and results of health systems. Key indicators provide information on health status, the determinants of health, health care activities and health expenditure and financing in OECD countries. Each indicator in the book is presented in a user-friendly format, consisting of charts illustrating variations across countries and over time, brief descriptive analyses highlighting the major findings conveyed by the data, and a methodological box on the definition of the indicator and any limitations in data comparability.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Masoud Dara, WHO Regional Office for Europe
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Similar to Presentation: Launch of the Knowledge Hub on Health and Migration (20)
Reported measles cases for the period November 2020—October 2021 (data as of 02 December 2021).A monthly summary of the epidemiological data on selected vaccine-preventable diseases in the WHO European Region
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
4. 4
The Knowledge Hub on Health
and Migration
Migration and health
multi-stakeholder
knowledge sharing
platform
Scientific and capacity-
building forum
Aim:
Improve public policies and interventions to address the
health needs of migrants and the public health
implications of migration in the WHO European Region
5. The Knowledge Hub
5
Collaboration and interaction between health and non-health sectors
Gather good practices, experiences, evidence-based approaches
Iimproving countries’
preparedness
Promoting people-
centred health
systems
Reducing health
inequalities
6. Looking forward to a good collaboration
with Sicily
• Similar to the extensive and close
collaboration with Italy
6
7. Extensive collaboration with
Italy over decades
• Member of WHO Governing Bodies
• SCRC now
• EB from 2017
• Pan-European conference in Rome in
November 2015 on migration and health –
migration/health strategy
• 2018: Italy hosts the Regional Committee for
Europe
8. Life expectancy trends in Italy
Life expectancy at birth (years), males Life expectancy at birth (years), females
70
75
80
85
1980 1990 2000 2010 1980 1990 2000 2010
European Region EU15 Italy
Source: WHO/Europe: European Health for All database
8
9. Proportion of population aged
65 and over and birth rate
% of population aged 65+ years Live births per 1000 population
8
12
16
20
1980 1990 2000 2010 1980 1990 2000 2010
European Region EU15 Italy
Source: WHO/Europe: European Health for All database
9
10. Mortality by broad cause,
all ages
SDR, Infectious and parasitic
diseases, per 100000
SDR, Neoplasms, per 100000
SDR, Diseases of the circulatory
system, per 100000
SDR, Diseases of the respiratory
system, per 100000
SDR, Diseases of the digestive
system, per 100000
SDR, External causes of injury and
poisoning, per 100000
5
10
15
20
160
200
240
100
200
300
400
500
50
100
150
20
30
40
50
60
20
40
60
80
1980 1990 2000 2010 1980 1990 2000 2010 1980 1990 2000 2010
1980 1990 2000 2010 1980 1990 2000 2010 1980 1990 2000 2010
European Region EU15 Italy
Source: WHO/Europe: Mortality indicator database
10
11. Premature mortality
(064 years), by broad cause
SDR(0-64), Infectious and parasitic
diseases, per 100000
SDR(0-64), Neoplasms, per 100000
SDR(0-64), Diseases of the
circulatory system, per 100000
SDR(0-64), Diseases of the
respiratory system, per 100000
SDR(0-64), Diseases of the digestive
system, per 100000
SDR(0-64), External causes of injury
and poisoning, per 100000
5
10
15
60
80
100
50
100
10
20
30
10
20
30
25
50
75
1980 1990 2000 2010 1980 1990 2000 2010 1980 1990 2000 2010
1980 1990 2000 2010 1980 1990 2000 2010 1980 1990 2000 2010
European Region EU15 Italy
Source: WHO/Europe: Mortality indicator database
11
13. Infant mortality, life expectancy and all-cause mortality
in Sicily and comparison with EU regions,
around year 2013
Indicator Sicily Comparison with EU
regions (quintiles)
(2010)
Infant mortality rate (deaths per 1000
live births)
4.14
Life expectancy at birth – females (years) 83.4
Life expectancy at birth – males (years) 79.0
WHO/Europe: Equity in health project – interactive atlases, http://data.euro.who.int/equity
14. All-cause and amenable mortality in Sicily and
comparison with EU regions, around year 2013
Indicator Sicily Comparison with EU
regions (quintiles)
Age standardized death rate (ASDR) per 100 000 population, all
causes, all ages, females
705.2
ASDR per 100 000 population, all causes, all ages, males 1038.3
ASDR per 100 000 population, all causes, all ages, both sexes 967.8
ASDR per 100 000 population, amenable causes, 2064, both sexes 116.75
WHO/Europe: Equity in health project – interactive atlases, http://data.euro.who.int/equity
15. Causes of amenable death Standardized
death rate by residence 2013 (all ages)
GEO/SEX
Malignant
neoplasm of
colon,
rectosigmoid
junction,
rectum, anus
and anal
canal
Malignant
neoplasm
of liver and
intrahepatic
bile ducts
Malignant
neoplasm
of
trachea,
bronchus
and lung
Alzheimer
disease
Ischaemic
heart
diseases
Acute
myocardial
infarction
including
subs.
myocardial
infarction
Cerebrova
scular
diseases
Asthma and
status
asthmaticus BPCO
Malignant
neoplasm of
breast
(Females)
Malignant
neoplasm
of cervix
uteri
(Females)
European
Union (28
countries) 31.29 10.51 55.15 17.83 131.87 50.08 88.68 1.38 33.52 33.19 4.03
Italy 27.75 14.57 50.51 14.52 104.16 37.94 84.11 0.64 28.87 31.63 1.23
Sicily 29.06 13.59 46.56 15.19 103.83 38.20 115.42 0.60 6.77 29.91 1.27
16. Availability of hospital beds and human
resources for health in Sicily and comparison
with EU regions, around year 2013
Indicator Sicily Comparison with EU
regions (quintiles) 2010
Hospital beds per 100 000 inhabitants 470.3
Physicians per 100 000 inhabitants* 705.5
WHO/Europe: Equity in health project – interactive atlases http://data.euro.who.int/equity
17. Social gradient in Italy – disposable household
income and life expectancy, around 2010
18. Social gradient in Italy – disposable household
income and amenable mortality, around 2010
19. Social gradient in Italy – long-term
unemployment and amenable mortality,
around 2010
20. Social gradient in Italy – long-term unemployment and
premature mortality (064 years) from ischaemic heart
disease among males, around 2010
21. Summary of findings
• Infant mortality in Sicily is high, in the highest quintile of the EU
regions.
• Life expectancy in Sicily is close to the average of all EU regions
and is the second lowest in Italy.
• Inequalities in social determinants like disposable income and long-
term unemployment are large between Italian regions.
• In Italy, the difference between the regions with highest and lowest
life expectancy is 2.5 years;
• Sicily has one of the highest densities of physicians in the EU, but
the availability of nurses and hospital beds is below average;
• There is considerable inequality at regional level in Italy, and health
outcomes like life expectancy and amenable mortality show strong
correlation with social determinants.
22. Sicily: facts and figures
on migration
22
Migrants arriving in Sicily through the
Mediterranean Sea
Foreign citizens living in Sicily
and their origin
25. Health equity and determinants at the
heart of Health 2020
Lifestyle, social, economic and
environmental determinants of health
Health equity
Good governance
26. Towards a roadmap for implementation of the SDGs
in the European Region
27. PARTNERSHIPS
Agenda 2030:
Health is central to development
Health and
well-being are
an outcome,
a determinant and
an enabler
of the 17 SDGs
28. PARTNERSHIPS
Speaking one language
HEALTH DISCOURSE DEVELOPMENT DISCOURSE
Health equity Leave no one behind
Social, economic and environmental determinants Social, economic and environmental dimensions
Empowerment Empowered people
Resilient communities
Life course
Rights- and gender-based Rights- and gender-based
Whole-of-society
Whole-of-government
Health in all policies Health in all SDGs
Good governance and peace-building
Resilient nations
29. We are on track towards
a healthier Europe
Premature mortalityLife expectancy
31. The early years and childhood
Health inequities have a strong association with material conditions and experiences
Source: Life Gets Under Your Skin, International Centre for Life course Studies in Society
and Health (ICLS), 2012
• Low birth weight
• Not being breastfed
• Maternal depression
• Having a lone parent
• Median family
income <60% of
average
• Parental
unemployment
• Maternal
qualifications
• Damp housing
• Social housing
• Area deprivation
32. Gender inequity: longer life expectancy for women but
more years in poor health
Global Health Observatory (GHO) data [online database]. Geneva: World Health
Organization; 2016 (http:// www.who.int/gho/en/, accessed 20 July 2016)
34. The working years
• Long durations of involuntary unemployment (three or more years)
in young men significantly predict heavy drinking and more frequent
drinking at ages 2735 years.
• Those who experienced long-term unemployment before the age of
33 are more likely to report risky health behaviours than those who
had not experienced unemployment, including those from more
advantaged backgrounds.
• Poor mental health is more prevalent among workers with non-fixed
temporary employment and those without contracts than among
workers with permanent or fixed temporary employment contracts.
• There is a 50% increased risk of fatal and non-fatal cardiovascular
events in those experiencing work-related stressors and this follows
a social gradient.
35. • There is a positive association between unemployment and hospitalization for all causes in the Belgian provinces.
• There is a strong association between long-term unemployment and hospitalization for cerebrovascular disease in adult males.
Unemployment as a risk for NCDs
Belgian provinces with higher unemployment rates = higher illness rates
Equity in health project – correlation map atlas, WHO/Europe 2012
35
36. Increasing European and international attention on reducing
inequities
Income
inequalities
Employment &
educational
inequalities
Health inequities
Good governance
for equitable
development
37. A joint monitoring framework for
Health 2020, NCDs and SDGs
Alcohol
Educational attainment
Health expenditure
Household consumption
Mortality
Reducing income inequality
Sanitation
Smoking
Social support
TB treatment
Unemployment
Vaccination
38. Towards a roadmap for
implementation of the 2030 Agenda
Roadmap
Consultations
with experts
Consultation
with civil
society
Consultations
with UN
agencies
Online
review
SCRC
Joint assessment missions
WHO/Europe has been collaborating closely with Italian Ministry of Health and the Sicilian health authorities in the area of migration since the start of the Arab Spring in 2011. A first assessment mission took place in Lampedusa in March 2011. Since then, joint Ministry of Health and Regional Health Authority assessment missions were repeated in Sicily in 2012, 2013 and 2014 due to the changing scenario and flow of migrants and refugees with the aim to upgrade the regional health capacity to respond to the large arrivals of migrants and refugees.
Contingency planning
In the context of the large-scale arrivals of migrants to Sicily, one of the main recommendations that resulted from the several assessment missions was the need to develop a migration health contingency plan.
Preparations for the development of the contingency plan started in April 2014 in collaboration with WHO/Europe. By that time over 6,000 migrants were arriving to Sicily in a week.
The contingency plan was publicly launched in September 2014 in Sicily. Sicily became the pioneer and an example for other countries in the WHO European Region in the development of an operational health strategy to respond to these large-scale arrivals. Sicily’s contingency plan was adapted as a law by the Regional Parliament of Sicily on 23 September 2014.
Panorama case study
A case study was published on the first issue of the new WHO/Europe public health journal, Panorama. This case study described the process undertaken jointly with the Ministry of Health and regional health authorities in Sicily since the preparation of the first assessment missions to the development of the contingency plan and its adoption as law.
Workshop for toolkit consultation
The Toolkit to assess health-system capacity for large arrivals of refugees and migrants has been up to today tested in assessment missions conducted jointly with Ministries of Health and regional health authorities in 13 countries (Italy, Portugal, Malta, Spain, Greece, Cyprus, Croatia, Slovenia, Serbia, Hungary, FYROM, Bulgaria, Albania).
As part of the consultation process for the finalization of this toolkit, a technical workshop was held in Palermo, Sicily, organized by WHO/Europe with the support of the Health Regional Councillor of the Sicily region and the Sicilian Medical Association. 15 technical experts gathered at the workshop from the ministries of health of Greece, Italy, Malta, Portugal, and WHO/Europe.
The toolkit has been finalized in collaboration with IOM and UNHCR, and its launch is planned for 18 December 2016 on International Migrants Day.
Workshop for toolkit consultation
The Toolkit to assess health-system capacity for large arrivals of refugees and migrants has been up to today tested in assessment missions conducted jointly with Ministries of Health and regional health authorities in 13 countries (Italy, Portugal, Malta, Spain, Greece, Cyprus, Croatia, Slovenia, Serbia, Hungary, FYROM, Bulgaria, Albania).
As part of the consultation process for the finalization of this toolkit, after a 1st consultation health in Rome and hosted by Ministry of Health of Italy a technical workshop was held in Palermo, Sicily, organized by WHO/Europe with the support of the Health Regional Councillor of the Sicily region and the Sicilian Medical Association. 15 technical experts gathered at the workshop from the ministries of health of Greece, Italy, Malta, Portugal, and WHO/Europe.
The toolkit has been finalized in collaboration with IOM and UNHCR, and its launch is planned for 18 December 2016 on International Migrants Day.
Tool Kit: The Italian and Sicily Region migration health experience was paramount in inspiring the development of a first world Toolkit for assessing health system capacity to manage large influxes of refugees, asylum-seekers and migrants.
In recent years, the WHO European Region has seen a marked increase in arrivals of mixed flows of refugees, asylum-seekers and migrants. Their journey to Europe is often long and treacherous, with numerous health and safety risks along the way. It is imperative that the health needs of these vulnerable groups be addressed by transiting and receiving countries using human rights principles and with careful coordination across sectors. The Toolkit for assessing health system capacity to manage large influxes of refugees, asylum-seekers and migrants was developed by the WHO Public Health Aspects of Migration in Europe (PHAME) project, funded by Italian Ministry of Health because refugees, asylum-seekers and migrants arriving in large groups present a particular set of individual and public health needs, and assessment of preparedness and capacity requires a specialized approach.
The aim of the present toolkit is to support national ministries of health in leading multisectoral collaboration to optimize the capacity of the health sector to manage large influxes of refugees, asylum-seekers and migrants, consequently improving their health and reducing health inequities.
Knowledge Hub responds to the need of an educational institute devoted to international migration and public health in the WHO European Region.
AIM: providing a scientific and capacity-building forum, supported by a multi-stakeholder platform, to develop and improve public policies and interventions to address the public health implications of migration in the WHO European Region by:
Improving health and well-being of the refugee, migrant and resident population
Reduce health inequalities
Promote migrants health systems sensitivity
Provide evidence based capacity-building
Develop public health policies for health and migration across the WHO European Region
The objectives of the Knowledge Hub are grounded on the WHO/Europe health policy framework, Health 2020, as well as the 2030 Agenda for Sustainable Development.
Its work will contribute to the implementation of the Strategy and action plan for refugee and migrant health in the WHO European Region, adopted by the Regional Committee for Europe in September 2016.
Objectives
To increase knowledge and awareness of health and migration stakeholders regarding good practices and evidence-based approaches by:
- Gathering and collating experiences, good practices, knowledge and evidence-based approaches from the whole WHO European Region and other relevant WHO regions.
- Fostering knowledge transfer of good practices and evidence-based approaches on health and migration for effective implementation into policies and programmes.
To recognise and recommend good practices and evidence-based approaches to improve health and health care of asylum-seekers, refugees and migrants.
To promote collaboration and interaction among health and migration stakeholders by:
- Supporting action-oriented research and policy analysis on health and migration;
- Engaging governments, scientists, public health specialists, IGOs and NGOs, civil society and all key stakeholders from the health sector and non-health sector, in addressing the public health aspects of migration through a participatory approach.
To contribute to improving countries’ preparedness and capacity, promoting people-centered health systems and reducing health inequalities within asylum-seekers, refugees and migrants.
No doubt that if you should choose a country based on where you can live longer, then Italy would be the right place to be (the wonderful food and wine notwithstanding).
In 2012, life expectancy for males was 79.8 years and 84.8 years for female. This is stable and much higher than the European average.
However, Italy has an ageing population.
In fact, Italy has the highest proportion of population aged 65+ in EU15 in year 2012 (21%).
If we take a look at the mortality for all causes, Italy has one of lowest mortality rates in EU15, especially for age groups 30-44 (females), 45-59 (males and females), 60-74 (males and females);
Additionally, Italy also has low mortality rates from diseases of respiratory and digestive system as well as external causes compared to EU15 average.
Italy is also doing well in terms of premature mortality: mortality rates are below EU15 average for neoplasm, diseases of circulatory, respiratory and digestive system, injury and poisoning;
Also in terms of Major noncommunicable diseases, mortality rates are below EU15 average for males and females.
In Italy the infant mortality rate was 3.7/1000 during 2005, lower than the average IMR for the European Region 4.94/1000 ). Sicily is the Italian Region with the highest IMR, 4.5 per 1000 live births in year 2010. This value is among the highest in the regions of the EU.
Life expectancy for males, females and both sexes is slightly above average than other regions in the European Union but lower than the Italian average ( male 79,8 and females 84,8 in 2012 ) .
All cause mortality, and age standardized rates are somewhat below average of EU regions .
Situation is similar also for amenable mortality, deaths that are considered to be avoidable through appropriate and timely health care interventions.
Asma 0,60 BPCO 30,23 Demenze 38,01 Infarto miocardico acuto 38,20 Influenza 0,37 Malattia di Alzheimer 15,19 Malattie cerebrovascolari 115,42 Malattie ischemiche del cuore 103,83 Polmonite 6,77 Traumi e incidenti 31,63 Tumore maligno del colon-retto 29,06 Tumore maligno della cervice uterina 1,27 Tumore maligno della mammella 29,91 Tumore maligno della trachea, dei bronchi e del polmone 46,56 Tumore maligno primitivo del fegato e dei dotti biliari intraepatici 13,59 Totale complessivo 500,67
The density of hospital beds is one of the lowest values in the European Union.
However, the density of physicians is high, placing Sicily in the quintile of the European Regions with highest availability of physicians.
Density of nurses and midwifes is 589.9 per 100 000 inhabitants, which is below average of European Regions.
According to the national trend, Sicily is decreasing the hospital capacity and planning to shift partially the health care activities towards primary care settings.
This is a European trend that we support.
Italy provides one of the highest level of accessibility for irregular migrants to healthcare services at the European level. In 1998 a National law ensured to migrants the access to emergency care, hospital care and prevention services, cost free and anonymous. Primary care is not guaranteed by this law, but each region can choose if and how to guarantee it to undocumented migrants. With the increase of migratory flows, the health care activity increased and covered also the health care assistance during sea rescue and into migrants` hosting centers.
In 2014 the Sicily Region approved a contingency plan, developed with the support of WHO, in order to strengthen the governance and the organization of the health system, facing increased migratory flows. In the same year, the Sicily Region guaranteed access to undocumented minors to primary care.
In Italy, there is relatively strong association between disposable household income per inhabitant (x axis) and life expectancy (y axis).
Sicily is the highlighted data point.
In Italy, there is strong association between disposable household income per inhabitant (x axis) and amenable mortality (y axis).
Sicily is the highlighted data point.
In Italy, there is strong association between long term unemployment (x axis) and amenable mortality (y axis).
Sicily is the highlighted data point.
In Italy, there is strong association between long term unemployment (x axis) and premature mortality (0-64 years) from ischaemic heart disease among males.
Sicily is the highlighted data point.
Over 1 Million crossed the Mediterranean sea in 2015 with majority arriving to Greece; and with an estimated 3771 drowned or went missing along the way.
Over 300,000 have risked their lives to reach Europe by sea so far in 2016. Data recorded in October 2016, 12% increase compared to the same period of 2014 and 2015.
20,500 unaccompanied children have arrived to Italy since the beginning of January 2016. No unaccompanied children have been relocated from Italy yet, but Italy will carry out first pilot transfer of unaccompanied children.
UNHCR Data October 2016
Let us see now what is the situation in Europe. In the last 30 years we made good progress n Europe in health outcomes and we gained 5 years in LE which is a tremendous success story. But inequities – although improving – still scar our region.
Let us take life expectancy with this perspective in mind: Europeans are living longer and the differences between countries in health outcomes are shrinking: a clear sign that inequalities are declining.
But the gap between the countries with the highest and lowest life expectancy is still 11 years.
Only a few countries have the privilege to enjoy the higher figures and Italy is one of them.
Health and health equity is at the heart of Health 2020 and is one of our 2 strategic objectives.
To make progress, we have to address all determinants of health: economic, social, environmental, health behaviour – as well as we need intersectoral governance for health.
Health 2020 is also a route towards the implementation of the 2030 Agenda for Sustainable Development in the European Region as the two are fully aligned.
Today, more than one year after the UN General Assembly adopted the Agenda 2030 with the 17 Sustainable Development Goals, the centrality of health as outcome, determinant and enabler for sustainable development is widely acknowledged. And if we work smart and well coordinated on the implementation of Health 2020 and the Agenda 2030, partnering across all sectors and society, there clearly will be synergies and co-benefits for our investments in health and sustainable development.
I would like to demonstrate this alignment to you.
A quick look at the key conceptual terms used in the health discourse on the one hand and the development discourse on the other shows the close alignment. Just to highlight a few examples: The key strategic objectives of health equity and whole-of government and whole-of-society approaches in Health 2020 – and the overarching focus on ‘Leave no one behind’ and good governance of the Agenda 2030; and we see social, economic and env. actors as relevant determinants for health and well-being in H2020 and at the same time as key pillars for sustainable development.
The concept of resilient communities and nations is featuring strongly in both frameworks, as does the concept of empowered people as a pre-condition for well-being and sustainable development.
The rights- and gender based approach – is there in both frameworks. And the life course approach? Although the term does not exist explicitly in the Agenda 2030, many of the targets of the SDGs fully reflect the life course concept including intergenerational responsibilities, and by advancing the debate like we did through the Minsk Declaration on the life-course Approach in the Context of Health 2020 last year – act early, act appropriately and on time during the life’s transitions, act together – we underline our forward looking approach and strong focus of improving impact.
In this regard we have reason to feel good about some of the progress we are making
For example: Europeans continue to live longer and healthier lives than ever before.
As this slide shows, the differences in life expectancy and premature mortality between countries across the region are diminishing.
Yet, profound challenges remain: the absolute differences in health status between the countries remain substantial ( 12,5 years difference in life expectancy between the lowest and highest figure in Europe ) and within countries inequities also continue.
These inequities in health are mainly linked to economic and social inequalities ( linked to globalization, economic processes ( such as liberalization and free trade - unless they are coupled with a social protection scheme. Opex markets require strong state and storng social protection, otherwise the result is what we have seen with the Brexit or what we see with the migration wave (economic migration).
On this slide we can see how education, income and material conditions are linked to health inequalities in Europe. Interestingly material deprivation has the strongest effect .
We know that these gaps are largely avoidable with good policy.
We also know the policies and sectors that are important for increasing equity in health.
The evidence is rich and convincing – as we all have been working hard in recent years to develop such evidence. Now we are discussing policy recommendations.
This work requires that we reach out to the other sectors. Why?
Health inequalities in early years have a strong association with adverse material conditions and experiences.
Homelessness, abandonment, neglect, material deprivation, parental unemployment - these all increases the risks of low mental wellbeing, higher stress and anxiety levels, poorer schools attendance & grades and an increased risk of developing health problems in later life.
These are also priorities for the education, labour and welfare sectors as well as for Health
Women overall live longer than men with a 12,5 years difference in the region but this mortality advantage of women also hides years of mental and physical disability, like in Andorra where there is the highest life expectancy, they spend the last 12 years in ill health;
these are also priorities for the social sector and for local authorities
Lower development indicators such as GDP, employment, wages & earning often correlate with poorer health outcomes.
The visible effects are geographic inequities within countries.
For example in Hungary there is a 9,5 years gap in adult Life Expectancy between different micro-regions , reflecting higher rates of material deprivation and employment insecurity. And the same patterns exist in all our countries as we can see on the slide, including in Nordic and Baltic countries.
In Hungary, the bad health status of the population and inequity in health – causes an economic loss of appr 12 % of the GDP. It clearly hinders economic growth.
When we are focusing on action it is obvious that reducing geographic inequities is also a priority for the development and the labour sectors and for the sustainability of our town and cities.
Not being in employment, education and training in youth and during working years is particularly associated with an increased risk for NCDs.
As the figures on this slide show.
This is particularly alarming as precarious employment and low-paid jobs have increased significantly in the last 7 years across the EU contributing to higher rates of unemployment and ‘in-work’ poverty.
This is particularly affecting youth and migrants and those with fewer years in education.
This slide shows an example from Belgium where we can see higher GP consultations for mental health problems and higher hospitalization rates for cerebrovascular diseases in the areas where there are higher rates of people in non-fixed temporary employment and those without contracts.
These are priorities for the health, education, labour, welfare and finance sectors together.
All of this data show us the necessity of cross sectoral action to increase equity in health BUT also how the benefits are shared by many sectors and deliver improvements for local people and for wider societal goals.
We need to intensify our combined policy efforts making health and equity a whole of government goal.
In this regard we are now at an interesting time in Europe and globally in our efforts to create the conditions for societies that are healthier, inclusive and sustainable.
As this slide shows there is a convergence of interests across diverse communities of practice and from many disciplines including economics, health, labour, and environment and from the perspectives of rights & justice.
As the WHO Regional Office for Europe, we have worked together with Member States to develop Health 2020 indicators and improve data collection, and developed a monitoring system with national targets that allows improved reporting, follow-up and review processes. The Agenda 2030 with its many targets and indicators, its international reporting requirements, and its still largely unresolved challenge how to disaggregate data to measure progress along various dimensions of inequality, constitutes additional challenges in our effort for better evidence of outcomes and impact. We, at the WHO Regional Office for Europe, have started the process of reviewing the further harmonization of indicators, reporting mechanisms and analysis across the Health 2020 and Agenda 2030 frameworks and will assist Member States, also through our Healthy Setting Networks, in this endeavour. It is, and will be again, an area in which much can be learnt from innovations on regional level, and we are looking forward to an even more intensified collaboration in this area with you.
We now need to develop a regional roadmap to implement the SDGs. This will build on what we have already achieved. From an initial mapping carried out, it becomes apparent, that the implementation of the SDGs requires:
A review and identification of regional priorities towards 2030.
A stronger focus throughout on governance and inter-sectoral action for health as well as “no-one left behind”
Alignments of national development and health policies and policy coherence across multiple goals
A stronger focus on the means of implementation, is also required, to both advance Health 2020 and the SDGs. This will certainly include strengthened public health capacities, more partnership, increased financing for health, innovation, further research, and enhanced monitoring and accountability
We are ready to work with all of you. We plan to consult with political and societal leaders, technical and professional experts, civil society, UN agencies, in various forums, including virtual forum, with all of you, and provide a regular update to the Standing Committee of the Regional Committee.
Health 2020 and Agenda 2030: Whether through ‘health for all’ or ‘leaving no one behind’ – we will work for the well-being and sustainable development of current and future generations.